Role of Mirtazapine in the Treatment of Antipsychotic-Induced Akathisia

  title={Role of Mirtazapine in the Treatment of Antipsychotic-Induced Akathisia},
  author={Robin Hieber and Timothy Dellenbaugh and Leigh Anne Nelson},
  journal={Annals of Pharmacotherapy},
  pages={841 - 846}
Objective: To evaluate the role of mirtazapine in the treatment of antipsychotic-induced akathisia. Data Sources: MEDLINE (1966–February 2008) and PsycINFO (1967–February 2008) were searched using the terms akathisia and mirtazapine. A bibliographic search was conducted as well. Study Selection and Data Extraction: All English-language articles identified from the search were evaluated. All primary literature was included in the review. Data Synthesis: Antipsychotic-induced akathisia can be… 

Tables from this paper

The Tolerability of Mirtazapine Augmentation in Schizophrenic Patients Treated with Risperidone: A Preliminary Randomized Placebo-controlled Trial
  • Jieun Lee, S. Cho, Sang-Hyuk Lee
  • Medicine, Psychology
    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2011
The results suggest that mirtazapine augmentation can be tolerable in schizophrenic patients treated with risperidone; however, one should pay attention to the weight gain with mirtzapine.
Akathisia and second-generation antipsychotic drugs
Even though akathisia is less prevalent with SGAs than with the first-generation drugs, it remains clinically important and all clinicians should be conversant with its recognition and management.
Mirtazapine – A Multifunctional Drug: Low Dose for Akathisia
The addition of low-dose mirtazapine to typical antipsychotics that exert predominant D2 receptor antagonism was suggested, supporting the hypothesis regarding the distinct pharmacological mechanisms underlying antipsychotic-induced extrapyramidal adverse effects and encouraging modification of treatment guidelines for acute akathisia.
Off-label uses of trazodone: a review
The possibility that a combination of trazodone with SSRIs may prevent or treat some of the SSRI side effects, such as anxiety, insomnia and sexual dysfunction, in addition to synergically increasing SSRI' antidepressant activity is discussed.
Review of the use of mirtazapine in the treatment of depression
Mirtazapine is a medication unlike other agents used for depression both in its mechanism of action as well as its side effects, and knowing these distinct characteristics will enable physicians to better utilize this agent for the benefit of their patients.
Pimavanserin: An Inverse Agonist Antipsychotic Drug.
  • R. Howland
  • Psychology, Medicine
    Journal of psychosocial nursing and mental health services
  • 2016
Based on its inverse agonist effect at 5HT2A receptors, pimavanserin may have potential for treating symptoms associated with the use of hallucinogen drugs and for treating akathisia associated with antipsychotic medications.
[Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 1 : Dystonia, akathisia und parkinsonism].
Assessment of the relevant studies on the prevalence, risk factors, prevention and treatment options and instruments for early prediction of acute AIMD in schizophrenic psychoses finds acute AimD is easily to recognize but is not always effectively and durably treated.
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.
Nine drugs which have been identified as an underutilized therapeutic resource for patients who have not responded to other drugs for schizophrenia and/or bipolar disorder are identified.


Atypical Antipsychotic–Induced Akathisia with Depression: Therapeutic Role of Mirtazapine
Mirtazapine is efficacious in treating atypical antipsychotic–induced akathisia and may be a good option, particularly in patients with coexisting depression, as well as its use in alleviating comorbid depressive disorder.
Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.
First results of a single-blind trial of ritanserin in the treatment of neuroleptic-induced akathisia are encouraging and warrant further studies.
Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin
Mianserin at a low dose may be a promising therapeutic option for patients with acute neuroleptic-induced akathisia, as well as by other relevant clinical rating scales.
Treatment of Neuroleptic-Induced Akathisia With the 5-HT2A Antagonist Trazodone
Trazodone is found to be a beneficial and relatively safe medication for the treatment of antipsychotic medication-induced akathisia and some improvement was noted in symptomatology of anxiety, depression, and psychosis.
Mirtazapine‐induced akathisia
It is suggested that mirtazapine’s adrenoceptor action might be the basis for the occurrence of akathisia in patients with chronic depression, and two cases of acute akath isia associated with mirtzapine are reported.
Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
A potential role for mirtazapine in the negative symptoms of schizophrenia is suggested, and there was no difference between the groups on the Hamilton depression scale at endpoint, suggesting that the improvement in negative symptoms was not an artifact of mood improvement.
The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study
Findings suggest a potential role for mirtazapine as an augmentation strategy in the treatment of negative symptoms of schizophrenia.
Cyproheptadine Versus Propranolol for the Treatment of Acute Neuroleptic-Induced Akathisia: A Comparative Double-Blind Study
It is concluded that cyproheptadine 16 mg/day is as effective as propranolol for the treatment of acute NIA and the antiakathisic effect of cypro heptamines may be mostly attributable to its serotonin antagonistic activity.
Managing Antipsychotic-Induced Acute and Chronic Akathisia
Based on the available literature, propranolol or other lipophilic β-blockers seem to be the most consistently effective treatment for acute akathisia and addition of benzodiazepines would appear to be a sensible next choice, especially if subjective distress persists.